USPTO serial 79306128
DALRIADA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 18, 2022
- Examiner
- PAYABYAB, EDWARD TAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DALRIADA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James R Menker
James R Menker Holley & Menker, PAPO Box 331937Atlantic Beach, FL 32233UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business management consulting in relation to strategy, marketing, and production matters; development of marketing strategies and concepts for others; market assessment services; business project management services for the biotechnology and pharmaceutical sector | ACTIVE | — |
| 042 | Pharmaceutical research and development; biomedical research services; medical research laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on the subject of scientific research in the field of biochemistry and biotechnology; research and development of new products for others; research and development of medicines; scientific and technical consulting, research, and design services in the fields of pharmaceuticals, biopharmaceuticals, nanotechnology, drug delivery systems, drug carriers, drug delivery apparatus, and clinical studies and trials; scientific project management services for the biotechnology and pharmaceutical sector | ACTIVE | — |
| 045 | Consultancy relating to the management of intellectual property in the nature of patent management consultation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Dalriada Drug Discovery Inc.
- Other trademarks owned by Dalriada Drug Discovery Inc.
- Other trademarks owned by Dalriada Drug Discovery Inc.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named DALRIADA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 18, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 18, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 29, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 28, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 18, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 18, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 2, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 2, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 13, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 25, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 25, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 25, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 25, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 14, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 14, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 18, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 18, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 16, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 16, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 15, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 11, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |